Background and Aim: The main treatment aim in chronic pancreatitis (CP) is symptom control and especially pain relief. Management of stone-predominant CP is challenging and requires a multidisciplinary approach. Extracorporeal shock wave lithotripsy (ESWL) has emerged as the cornerstone of nonsurgical treatment as a result of disappointing results of available endoscopic treatment options during the last decades. With new developments in the field of direct peroral pancreatoscopy (POP) and intracorporeal lithotripsy, direct intraluminal treatment of main pancreatic duct (MPD) stones returns to the spotlight.
INTRODUCTION

C
HRONIC PANCREATITIS (CP) was first described surgically in an autopsy report in 1761 by JeanBaptista. 1 One hundred years later, the first endoscopic pancreatic sphincterotomy was carried out to remove pancreatic duct (PD) stones with a basket. 2 Howell et al. first described main pancreatic duct (MPD) stone removal under direct visualization with a 10-Fr baby endoscope using an electrohydraulic lithotripsy (EHL) probe in 1999. 3 Chronic pancreatitis is an ongoing inflammatory disease that leads to a fibrotic remodeling of the pancreatic tissue and finally functional loss with endocrine and exocrine insufficiency. 4 The incidence of CP increases with the consumption of alcohol and has a worldwide incidence of 1.6-23 per 100 000 with an increasing prevalence. 5 Moreover, the idiopathic cause can have a higher prevalence in some countries, especially in Asia. 6, 7 It can generally be categorized as toxic metabolic, idiopathic, genetic (i.e. such as SPINK1-or CFTR mutation), autoimmune (i.e. autoimmune pancreatitis (AIP) or lupus), recurrent and severe acute pancreatitis and obstruction. 8 Patients with CP present with various types of complications containing ductal strictures or disruption, biliary strictures, duodenal narrowing, pseudocysts, pancreatic malignancy and calculi. 9 Pancreatic calculi can be found in 50-90% of patients during long-term follow up. 10, 11 Pancreatic calculi lead to obstruction (Figs 1,2) of the duct and the ensuing ductal and parenchymal hypertension often causes severe pain. The origin of pain seems to be multifactorial with combinations of mechanisms such as pancreatic ductal hypertension, increased interstitial fluid pressure, ischemia and inflammatory damage of pancreatic nerves. 12 As a result of these variations of etiology of pain it is difficult to determine the leading factor in the individual case and there is a lack of parameters predicting success of different therapeutic options. Dilation of the main pancreatic duct of more than 7 mm is considered an indicator for increased ductal and parenchymal pressure causative of pain. The goal of all therapy in CP is symptom control and pain relief, which can be achieved by draining the obstructed main pancreatic duct and/or removal of obstructing pancreatic duct calculi. This treatment is challenging and needs a multidisciplinary team approach involving physician, endoscopist, radiologist and surgeon. 9 There are various treatment options including extracorporeal shock wave lithotripsy (ESWL), endoscopic retrograde pancreatography (ERP), peroral pancreatoscopy and surgery. Endotherapy is less invasive then surgery and therefore should be always offered to patients as a first step. In patients with extensive calculi or multiple strictures, endotherapy has its limitations. The ability to treat calculi under direct visualization might be an important step forward in an extended endotherapy. Our aim was to review the available data from publications and discuss the role of this technology in the past and in the future with a focus on efficacy and safety of different technologies of peroral pancreatoscopy (POP), endoscopes and lithotripsy devices.
Indications for endoscopic therapy and endoscopic treatment strategies
In different parts of the world, etiology, clinical manifestation and, in particular, patient duct morphology vary considerably. 13 Endoscopic treatment of symptomatic chronic pancreatitis usually depends on pancreatic ductal morphology and the presence of pancreatic stones. Complex ductal morphology and stricture-predominant disease is usually seen in patients with an alcoholic-related etiology whereas stone-predominant disease with a uniformly dilated pancreatic duct is often seen in patients with an idiopathic or genetic etiology. 12 As pancreatic stones are usually hard and impacted in the pancreatic duct (Figs 1,2) endoscopic treatment is often challenging to carry out, especially when combined with ductal strictures. Thus, ESWL has become the cornerstone of stone-predominant CP.
Approximately 18% 14 of patients with chronic pancreatitis present with main MPD strictures and 50% present with calculi.
11 Dominant PD strictures should be treated by dilatation and subsequent implantation of a single large-bore plastic stent (i.e. 10 Fr) with stent exchange within 1 year. Persisting strictures can be treated by simultaneous placement of multiple side-by-side stenting. 15 Small calculi can usually be extracted by Dormia basket or balloon sweep after endoscopic sphincterotomy (ESP) of the pancreatic sphincter. Larger calculi need fragmentation prior to endoscopic removal, usually done by ESWL. 15 Multiple studies have shown MPD clearance after ESWL of 59-80% 16 and long-term pain relief of 60-90%. 16, 17 Studies suggest that even ESWL alone is equal to ESWL followed by endoscopic retrograde cholangiopancreatography (ERCP). [18] [19] [20] However, ESWL has some limitations. It is not everywhere available, effective pain management with epidural catheter is recommended, general or i.v. anesthesia is needed and, particularly with more than one stone in different parts of the MPD, multiple sessions are required to facilitate effective fragmentation and MPD clearance. In addition, calculi with a density of >820.5 Hounsfield units seem to respond less effectively to ESWL. 21 As standard of practice, different interventions are needed for MPD clearance (ERCP, ESWL), which leads to additional procedures and costs. Endoscopic treatment has its limitations when it comes to isolated calculi in the tail region, multiple MPD strictures and stones all along the MPD. 17 Surgery should be considered after unsuccessful endotherapy and as a multidisciplinary team decision including radiologist, surgeon and endoscopist as it is associated with a relatively high morbidity and mortality rate (18-53% and 0-5%, respectively, for resection, 22 and 0-4% mortality for MPD drainage 23 ). 15 Therefore, new therapeutic strategies using direct visualization are under investigation to achieve MPD clearance in one ERP session.
METHODS
Search protocol and eligibility criteria T O DETERMINE THE efficacy and safety of POPguided treatment of MPD stones, a systematic Medline search was conducted. Abstracts from Digestive Disease Week (DDW) and United European Gastroenterology Week (UEGW) were searched manually. All published studies and case reports of pancreatoscopic lithotripsy were eligible. Search for relevant studies was carried out using the following text words and corresponding Medical Subject Headings: pancreatoscopy, chronic pancreatitis, laser lithotripsy, electrohydraulic lithotripsy, main pancreatic duct stones, ductal hypertension.
Available technologies for POP
After technological advances in fiberoptic duodenoscopy and the advent of small-caliber flexible fiberoptic instruments, peroral cholangioscopy and pancreatoscopy were introduced into clinical practice in 1976, opening new diagnostic and therapeutic options in biliopancreatic diseases. [24] [25] [26] Cholangiopancreaticoscopy was limited to visualization only with no therapeutic capabilities for another 23 years. Howell first reported on therapeutic POP in 1999, when he used a 10-Fr fiberoptic 'through the scope' endoscope (Olympus Medical Systems Corporation, Tokyo, Japan) to carry out EHL under direct visualization in MPD. 3 The 'mother-baby' technique represents the predominantly used approach of POP in contrast to direct peroral pancreatoscopy. However, the mother-baby technique never achieved wide clinical acceptance because of several critical limitations of the technique in that it requires two experienced endoscopists and the available reusable scopes are very fragile with high initial and repair costs and provide only limited maneuverability and poor irrigation capabilities. 27 Recently, a prototype video baby endoscope was developed (Olympus Medical Systems Corporation) and is currently being evaluated in clinical trials.
To overcome some of these aforementioned limitations, single-operator cholangioscopy (SOC) technology has been developed and was introduced in 2007 (SpyGlass DVS; Boston Scientific, Natick, MA, USA). The legacy system consisted of a disposable 10-Fr delivery catheter with fourway deflection capabilities and dedicated irrigation channels together with a fiberoptic probe with poor image quality for visualization. In 2015, single-operator video cholangioscopy (SpyGlass DS; Boston Scientific) was launched (Fig. 3) . The new technique enables high-resolution imaging with a 60% wider field of view, a larger working channel (1.2 mm) and an additional succinate option. Development of single operator pancreatoscopy in contrast to conventional POP technology simplified POP procedure and led to an increased use, mainly as a rescue therapy after failure of ESWL in endoscopic centers that have SpyGlass technology for bile duct interventions available.
Techniques for intracorporeal fragmentation of pancreatic stones
Fragmentation of complex difficult-to-extract and sometimes cast-like stones is needed to facilitate stone extraction during ERCP. Despite mechanical lithotripsy and ESWL, intraductal lithotripsy can be achieved by EHL and laser lithotripsy (LL).
Electrohydraulic lithotripsy
Electrohydraulic lithotripsy technique consists of a charge generator and a bipolar probe that generates sparks at its tip in an aqueous medium (Fig. 4) . The sparks create a vapor plasma and subsequently a cavitation bubble oscillating around the tip of the probe. Simultaneously, three distinctive shock-wave pulses are generated. The first shock wave is produced by rapid expansion of the vapor plasma, whereas the second and third waves are produced by rebounds of the cavitation bubble. The energy of these high-frequency hydraulic pressure waves is absorbed by nearby stones which results in their fragmentation. 28 The shock waves can cause inadvertent injury or perforation of the bile duct wall if the probe is not deployed close to the stone and away from the ductal wall. EHL can be carried out under fluoroscopic guidance by using centering balloons or direct cholangioscopic vision. The disadvantage of using only fluoroscopic guidance is related to the two-dimensional imaging and the inability to confirm correct positioning of the probe. Therefore, direct visualization is frequently preferred to avoid damage to the duct wall. EHL equipment is compact, requires no special electricity, and is relatively inexpensive.
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Laser lithotripsy
In laser lithotripsy, laser light at a particular wavelength is focused on the surface of the stone to induce wave-mediated fragmentation. The first successful use of a pulsed laser for shock-wave lithotripsy of bile duct stones was reported in 1986. 29 Laser technology is generally limited by reduced portability, high costs, and availability of more cost-effective alternatives. 26 A neodymium : yttrium-aluminum-garnet (Nd:YAG) laser produces a local shock-wave effect, whereas a flash lamp pulsed laser has a thermal mechanism. The frequency-doubled, double-pulse Nd:YAG (FREDDY) system, a combination of 532-nm green light (20%) and 1064-nm infrared light (80%), fragments stones through the initial formation of plasma on its surface, which then strongly absorbs the infrared light energy and produces a strong shock wave. Fragmentation by holmium:YAG lithotripsy occurs primarily by a photothermal mechanism whereby there is direct transmittance of energy from the laser to the stone 30 (Fig. 5 ). This mechanism is fundamentally different from other laser lithotripsy modalities and depends on laser energy absorption of light with a longer wave length of about 2100 nm on the surface of the stone as well as in the surrounding fluid. At the stone surface, melting and ejection of stone material occurs. This is then swept away by a vapor bubble that is created by water absorption of the laser energy. 31 Because the holmium laser produces a high effective energy level, clear ductal vision is important to prevent inadvertent bile duct injury. When done under direct cholangioscopic or pancreatoscopic vision it has a good safety profile. 31 Holmium:YAG laser lithotripsy of biliary stones was first reported in 1998. 30 Nevertheless, there are only a few reports of holmium laser lithotripsy of pancreatic duct stones. 31 To date, there is no prospective trial evaluating the differences in efficiency or safety of these two different techniques for lithotripsy of pancreatic calculi.
RESULTS
Role of pancreatoscopic-guided treatment U SING THE AFOREMENTIONED terms, systematic Medline search and manual search for abstracts found 42 publications. Of these, 10 relevant publications meeting the inclusion criteria were identified. There were only two prospective series, six retrospective trials and two case reports including 87 patients altogether (Table 1) . 3, [31] [32] [33] 36, [38] [39] [40] [41] [42] Only one trial consisted of more than 10 patients, prospective randomized controlled trials lacked completely. Thus, there are only limited, low-quality data available with small patient numbers mostly originating from subgroups of larger cohorts of patients out of trials with the primary aim of cholangioscopic treatment of common bile duct (CBD) stones.
Available data show successful ductal clearance for POPguided treatment of between 43% and 100% ( Table 1) . The reported success rate for ESWL is between 59% and 80%. 16 These data suggest that POP-guided lithotripsy seems to be effective in terms of ductal clearance with similar or better success rates compared to studies using ESWL ( Table 1) . Interpretation of these data is limited by the small number of cases for POP and the lack of prospective randomized controlled trials. There is only one study retrospectively comparing single-operator pancreatoscopy (SpyGlass; Boston Scientific) with the standard mother-baby technique showing no significant differences in success rate. 32 Even though the role of the different technologies used for intracorporeal lithotripsy is not yet fully investigated, there is a tendency for a higher success rate by using holmium laser in comparison to EHL.
Adverse event (AE) rate for POP-guided therapy is reported as 0-13.5% (Table 1) . One study by Ito et al. showed a noticeable higher adverse event rate of 43%. In this trial, POP was carried out after ESWL. 33 Adverse events were described mainly as pain and pancreatitis. There was no reported mortality following POP treatment.
The adverse event rate in ESWL is described as 5.8-6.7% with a mortality rate of 0.05% according to publications Digestive
with large numbers of patients. 15, 34, 35 Adverse events were mainly described as pain at the side of shock-wave delivery, bleeding and fever. A few serious adverse events were reported. These included internal bleeding, splenic rupture, biliary obstruction, bowel perforation, liver trauma and necrotizing pancreatitis. 16 Currently, POP-guided lithotripsy is still mostly used as a third-line therapy for complex and difficult-to-extract PD stones in centers that have the equipment and expertise on cholangioscopy and laser lithotripsy or EHL in CBD stones. 31, 36 Another potential indication for pancreatoscopic treatment is emergency lithotripsy for removal of a ruptured and incorporated Dormia basket after failed mechanical lithotripsy (Fig. 6) . Despite the few data available with no head-to-head randomized controlled trial, the current literature suggests an at least equal success rate compared to ESWL with an acceptable adverse event rate. A combination of Spyglass/EHL and ESWL seems to be related with a higher complication rate. 37 
DISCUSSION
S
INCE THE BEGINNING of endoscopic treatment of chronic pancreatitis, disintegration and extraction of complex pancreatic calculi in one ERCP session only was always welcomed. Technical limitations and drawbacks prevented a wider clinical use for a long time and led to a resignation in that field. Despite further technical improvements, therapeutic intervention in PD still seemed to be unreachable for endoscopists. This clearly changed with the introduction of the SpyGlass Legacy System (SpyGlass DVS; Boston Scientific). Since then, more and more studies investigated the possibility of endoscopic management of pancreatic calculi under direct vision. Yet, there is only lowquality evidence on a small number of published cases available, as most of the reported results are part of subgroup analysis in studies that had cholangioscopy as the first intent and therefore must be interpreted with caution. Nevertheless, the available results are very promising in terms of ductal clearance and pain relief compared to standard endoscopic techniques and ESWL as the current gold standard for lithotripsy. However, despite these favorable results and recent technical improvements, individual factors of pain onset such as localization of strictures and stones within the MPD, extent of MPD dilation and additional inflammation still determine the likelihood of successful POP-guided treatment. Currently available data are -probably as a result of the low number of cases -not adjusted to these parameters and may therefore be biased because of representing results of a preselected group of cases with favorable individual anatomical situations. Following the ESGE guidelines, ESWL is still the first-line therapy in our unit for PD stones. Our clinical experience is that availability of POP-guided lithotripsy can reduce the number of ESWL sessions especially in complicated PD stones and can be a first-line or rescue therapy in special situations. Available data show only a low risk of adverse events following POP-guided treatment. In our view, the results and adverse event rate of the trial by Ito et al. 33 with a reported seven cases of single-operator pancreatoscopy with EHL must be interpreted differently, because they represent results of POP-guided treatment as rescue therapy following failure of ESWL. This might result in a remarkably lower success rate and higher rate of overall and severe adverse events. Reasons for failure of ESWL remain unclear, but all stones were located in the pancreatic head. This location may have contributed to failure of consecutive POP-guided treatment, because stable positioning of the endoscope to visualize the stone in a location next to the papilla seems to be more difficult. However, if reported adverse events have occurred because of ESWL or POP alone, or as a result of a combination of both approaches, it cannot be clearly differentiated.
CONCLUSION
W ELL-POWERED RANDOMIZED CONTROLLED trials, also using large numbers of patients, are needed to prove efficiency and safety of the new technique 
